|
MIB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.281700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.465630E-01 |
| Normal-vs-Stage2 |
6.254200E-02 |
| Normal-vs-Stage3 |
5.938200E-02 |
| Normal-vs-Stage4 |
5.524500E-03 |
| Stage1-vs-Stage2 |
3.718000E-01 |
| Stage1-vs-Stage3 |
3.960400E-01 |
| Stage1-vs-Stage4 |
4.864100E-02 |
| Stage2-vs-Stage3 |
7.888600E-01 |
| Stage2-vs-Stage4 |
5.601000E-01 |
| Stage3-vs-Stage4 |
3.370000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.129240E-01 |
| Normal-vs-AfricanAmerican |
9.377000E-01 |
| Normal-vs-Asian |
5.339900E-02 |
| Caucasian-vs-AfricanAmerican |
2.399000E-01 |
| Caucasian-vs-Asian |
5.467600E-01 |
| AfricanAmerican-vs-Asian |
1.443230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.016600E-03 |
| Normal-vs-Female |
1.113030E-01 |
| Male-vs-Female |
8.605800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.820800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.926500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.918200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.060630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.242500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.331000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.315000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.155600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.099600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.507000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.099000E-01 |
| Classical-VS-Follicular |
4.617100E-04 |
| Classical-VS-Other |
1.759800E-01 |
| Classical-VS-Normal |
4.789600E-01 |
| Tall-VS-Follicular |
2.159000E-01 |
| Tall-VS-Other |
3.436200E-01 |
| Tall-VS-Normal |
1.205380E-01 |
| Follicular-VS-Other |
8.353000E-01 |
| Follicular-VS-Normal |
1.098700E-03 |
| Other-VS-Normal |
6.912100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.409520E-02 |
| Normal-vs-N1 |
7.612000E-02 |
| N0-vs-N1 |
7.733400E-01 |
|
|
